RT @Lacyjohnston123: Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study ..…
Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study ... https://t.co/xMS9a2T0Tx
RT @pash22: @susan_bewley @dompagano @clarky_on @dr_benoy_n_shah @MHRAgovuk @shanti_das @TomPMarshall @NICEComms Chk out 'Reporting of fina…
RT @pash22: @susan_bewley @dompagano @clarky_on @dr_benoy_n_shah @MHRAgovuk @shanti_das @TomPMarshall @NICEComms Chk out 'Reporting of fina…
@susan_bewley @dompagano @clarky_on @dr_benoy_n_shah @MHRAgovuk @shanti_das @TomPMarshall @NICEComms Chk out 'Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study' via @BrettThombs et al &
RT @pash22: Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study https://t.c…
RT @pash22: Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study https://t.c…
RT @pash22: Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study https://t.c…
Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study https://t.co/e1b2YtbIPL via @joel_lexchin et al @susan_bewley @dr_benoy_n_shah
RT @CMAJ: New research in CMAJ reveals undisclosed financial conflicts of interest in organizations that produce Canadian clinical guidelin…
RT @CMAJ: New research in CMAJ reveals undisclosed financial conflicts of interest in organizations that produce Canadian clinical guidelin…
RT @CMAJ: New research in CMAJ reveals undisclosed financial conflicts of interest in organizations that produce Canadian clinical guidelin…
RT @CMAJ: New research in CMAJ reveals undisclosed financial conflicts of interest in organizations that produce Canadian clinical guidelin…
#conflitsdIntérêt des #associations & des sociétés savantes qui rédigent les recommand. de bonne pratique sur les #médicaments au Canada, non déclarés. Les liens d'intérêt avec #BigPharma créent des biais en France aussi. #marketing, #influence, #désin
RT @CMAJ: New research in CMAJ reveals undisclosed financial conflicts of interest in organizations that produce Canadian clinical guidelin…
RT @eturnermd1: "Most Canadian national CPGs on the use of drugs are produced by disease or condition interest groups and medical professio…
RT @DrNancyOlivieri: Thanks @JeanneLenzer1 Practice #guidelines support MD decision-making, but may be influenced by #conflictsofinterest.…
Thanks @JeanneLenzer1 Practice #guidelines support MD decision-making, but may be influenced by #conflictsofinterest. Recent eg: 14 of 15 'disease interest’ groups disclosed #industry funding on websites but not in guidelines, more: https://t.co/ow4Rg8B0u7
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry. htt…
Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study | CMAJ https://t.co/bRaG39DntY
RT @HengartnerMP: Massive links to industry in producers of clinical practice guidelines - all financial conflicts of interest undeclared.…
RT @LisaMacRichards: Important new study showing Canadian clinical practice guidelines have a long way to go to eliminate conflict of inter…
RT @LisaMacRichards: Important new study showing Canadian clinical practice guidelines have a long way to go to eliminate conflict of inter…
RT @LisaMacRichards: Important new study showing Canadian clinical practice guidelines have a long way to go to eliminate conflict of inter…
Important new study showing Canadian clinical practice guidelines have a long way to go to eliminate conflict of interest. https://t.co/kWMsSfzEXe
RT @HengartnerMP: Massive links to industry in producers of clinical practice guidelines - all financial conflicts of interest undeclared.…
This is exactly why you never see any natural therapy recommendations for treating any clinical condition. Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study https://t.co/McFehYAxBI
RT CMAJ: New research in CMAJ reveals undisclosed financial conflicts of interest in organizations that produce Canadian clinical guidelines on medications: https://t.co/ONWuHmOdsA LDI_ILD CIUSSS_COMTL McGillMed #CDNhealth #pharma #medicalethics https://t.
RT @CMAJ: New research in CMAJ reveals undisclosed financial conflicts of interest in organizations that produce Canadian clinical guidelin…
RT @CMAJ: New research in CMAJ reveals undisclosed financial conflicts of interest in organizations that produce Canadian clinical guidelin…
RT @DrNancyOlivieri: Needs to change: #MDs who recommend (in “guidelines") drugs prescribed to CDNs paid by #BigPharma, including the compa…
RT @Drug_Evidence: "When CPG producers are funded by industry, full disclosure and independent oversight are needed. If governments and oth…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry. htt…
RT @HengartnerMP: Massive links to industry in producers of clinical practice guidelines - all financial conflicts of interest undeclared.…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study https://t.co/qSW7fz77eA https://t.co/HeuOAUp1xZ
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @CMAJ: New research in CMAJ reveals undisclosed financial conflicts of interest in organizations that produce Canadian clinical guidelin…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @GoldfriedMarvin: . When will we ever get our act together!?! .
RT @Links_Medicus: Reporting of Financial Conflicts of Interest by Canadian Clinical Practice Guideline Producers – via @CMAJ https://t.co…
Reporting of Financial Conflicts of Interest by Canadian Clinical Practice Guideline Producers – via @CMAJ https://t.co/ix1gAs3H9B
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry. htt…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @GoldfriedMarvin: . When will we ever get our act together!?! . https://t.co/cnDIcequsv
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @CMAJ: New research in CMAJ reveals undisclosed financial conflicts of interest in organizations that produce Canadian clinical guidelin…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @CMAJ: New research in CMAJ reveals undisclosed financial conflicts of interest in organizations that produce Canadian clinical guidelin…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @eturnermd1: "Most Canadian national CPGs on the use of drugs are produced by disease or condition interest groups and medical professio…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry. htt…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry. htt…
RT @GoldfriedMarvin: . When will we ever get our act together!?! .
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @CMAJ: New research in CMAJ reveals undisclosed financial conflicts of interest in organizations that produce Canadian clinical guidelin…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry. htt…
RT @eturnermd1: "Most Canadian national CPGs on the use of drugs are produced by disease or condition interest groups and medical professio…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry. htt…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
Yes, they also affect 4) Training. especially in connection with 2). In my grad school, I had quite a few profs who hadn't seen a client in 20-30 years, yet they were teaching people how to do "therapy"
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
. When will we ever get our act together!?! .
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
Ah ben. Conflits d’intérêts financiers des organisations responsables de la rédaction des Lignes Directrices et Standards de Pratique sur les médicaments au Canada (et pareil au Québec). Probablement la cause du biais anti-keto généralisé (keto c’est pas p
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @CMAJ: New research in CMAJ reveals undisclosed financial conflicts of interest in organizations that produce Canadian clinical guidelin…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @CMAJ: New research in CMAJ reveals undisclosed financial conflicts of interest in organizations that produce Canadian clinical guidelin…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.